BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 217790)

  • 1. Autoantibodies to islet cells in diabetes mellitus.
    Kaldany A
    Diabetes; 1979 Feb; 28(2):102-5. PubMed ID: 217790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
    Lander T; Nerl C; Held M; Standl E; Mehnert H
    Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral autoimmunity in diabetic patients].
    Pouplard A; Bottazzo GF; Doniach D
    Nouv Presse Med; 1977 Jan; 6(4):269-72. PubMed ID: 189288
    [No Abstract]   [Full Text] [Related]  

  • 4. Separate autoantibodies to human pancreatic glucagon and somatostatin cells.
    Bottazzo GF; Lendrum R
    Lancet; 1976 Oct; 2(7991):873-6. PubMed ID: 62113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and the endocrine pancreas.
    Doniach D; Bottazzo GF
    Pathobiol Annu; 1977; 7():327-46. PubMed ID: 339152
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.
    Ejiri K; Taniguchi H; Morimoto Y; Yamashiro Y; Baba S; Srikanta S; Eisenbarth GS
    Diabetes Res Clin Pract; 1990 Apr; 9(1):1-5. PubMed ID: 2161728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential lysis of pancreatic B-cells by islet cell surface antibodies.
    Dobersen MJ; Scharff JE
    Diabetes; 1982 May; 31(5 Pt 1):459-62. PubMed ID: 6759262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and pancreatic islet cell antibodies in diabetes [proceedings].
    Morris PJ; Vaughan H; McCallum CJ; Gray RS; Irvine WJ; Campbell CJ; Duncan LJ; Farquhar JW
    Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 795692
    [No Abstract]   [Full Text] [Related]  

  • 10. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies.
    Wagner R; McNally JM; Bonifacio E; Genovese S; Foulis A; McGill M; Christie MR; Betterle C; Bosi E; Bottazzo GF
    Diabetes; 1994 Jul; 43(7):851-6. PubMed ID: 7912208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to cultured human insulinoma cells in insulin-dependent diabetes.
    Maclaren NK; Huang SW; Fogh J
    Lancet; 1975 May; 1(7914):997-1000. PubMed ID: 48725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients.
    Palmer JP; Cooney MK; Crossley JR; Hollander PH; Asplin CM
    Diabetes Care; 1981; 4(5):525-8. PubMed ID: 6181949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-cell antibodies (ICA) in diabetes mellitus (evidence of an autoantigen common to all cells in the islet of Langerhans).
    Bottazzo GF; Doniach D
    Ric Clin Lab; 1978; 8(1-2):29-38. PubMed ID: 81509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Islet cell antibodies in diabetic patients with other autoimmune diseases (author's transl)].
    Pujol-Borrell R; Richart C; Marti S; Gomez JM
    Nouv Presse Med; 1981 Sep; 10(34):2791-3. PubMed ID: 7031598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determinación of islet-cell antibodies in different groups of diabetics (author's transl)].
    Pujol Borrell R; Richart C; Martí S; Martín C; Martínez-Vázquez JM; Bacardi Noguera R
    Med Clin (Barc); 1979 Jan; 72(1):13-6. PubMed ID: 372693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.
    Bottazzo GF; Dean BM; Gorsuch AN; Cudworth AG; Doniach D
    Lancet; 1980 Mar; 1(8170):668-72. PubMed ID: 6103089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of islet cell autoantibodies in newly diagnosed diabetic patients using insulin-producing Syrian hamster cells.
    Matsuba I; Marner B; Nerup J; Lernmark A
    Diabetes Res; 1987 Mar; 4(3):103-7. PubMed ID: 3301157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.